UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation

Cancer letters, 2016-10, Vol.381 (2), p.279-286

2016

Volltextzugriff (PDF)

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

International journal of cancer, 2017-04, Vol.140 (8), p.1870-1880

2017

Volltextzugriff (PDF)

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

Molecular and cellular endocrinology, 2014-03, Vol.383 (1-2), p.193-202

2014

Volltextzugriff (PDF)

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

Cancer letters, 2018-10, Vol.435, p.101-109

2018

Volltextzugriff (PDF)

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

International journal of cancer, 2018-05, Vol.142 (9), p.1842-1852

2018

Volltextzugriff (PDF)

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors

Endocrine-related cancer, 2019-02, Vol.26 (2), p.R95-R108

2019

Volltextzugriff (PDF)

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells

Cancer letters, 2021-01, Vol.497, p.77-88

2021

Volltextzugriff (PDF)

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion

Molecular and cellular endocrinology, 2021-01, Vol.520, p.111092-111092, Article 111092

2021

Volltextzugriff (PDF)

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Molecular and cellular endocrinology, 2019-09, Vol.495, p.110519-110519, Article 110519

2019

Volltextzugriff (PDF)

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Endocrinology (Philadelphia), 2014-08, Vol.155 (8), p.2932-2941

2014

Volltextzugriff (PDF)

Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance

Hormone and metabolic research, 2017-04, Vol.49 (4), p.259-268

2017

Volltextzugriff (PDF)

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation

Hormone and metabolic research, 2014-11, Vol.46 (12), p.845-853

2014

Volltextzugriff (PDF)

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

Cancer letters, 2017-10, Vol.406, p.54-63

2017

Volltextzugriff (PDF)

Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: First Italian series

Bone (New York, N.Y.), 2013-10, Vol.56 (2), p.276-280

2013

Volltextzugriff (PDF)

Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats

The Journal of pharmacology and experimental therapeutics, 2001-07, Vol.298 (1), p.34

2001

Volltextzugriff (PDF)

Combat veterans, mental health issues, and the death penalty: addressing the impact of post-traumatic stress disorder and traumatic brain injury

Fordham law review, 2009-05, Vol.77 (6), p.2955-2995

Giardino, Anthony E

2009

Volltextzugriff (PDF)

Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor

Thrombosis research, 2000-04, Vol.98 (1), p.83-93

2000

Volltextzugriff (PDF)

RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent

The Journal of pharmacology and experimental therapeutics, 1993-11, Vol.267 (2), p.648

1993

Volltextzugriff (PDF)

The educational value of pediatric emergency transport: By design or by default?

Pediatric emergency care, 1993-10, Vol.9 (5), p.275-280

1993

Volltextzugriff (PDF)

Medical education and resident work hours

JAMA : the journal of the American Medical Association, 1990-02, Vol.263 (5), p.620

1990

Volltextzugriff (PDF)

A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo

The Journal of biological chemistry, 2005-05, Vol.280 (18), p.18001-18007

2005

Volltextzugriff (PDF)

Cardiovascular Profile of RWJ 29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dogs

Journal of cardiovascular pharmacology, 1994-02, Vol.23 (2), p.300-310

1994

Volltextzugriff (PDF)

In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S 1 ‘ Subsite and Its Implications to Structure-Based Drug Design

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.1984-2008

2005

Volltextzugriff (PDF)

Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents. 4-Ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties

Journal of medicinal chemistry, 1989-05, Vol.32 (5), p.990-997

1989

Volltextzugriff (PDF)

Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist

Thrombosis research, 2001-10, Vol.104 (2), p.113-126

2001

Volltextzugriff (PDF)

1 – 25 von 564

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(409)
Mit Volltextzugriff
(405)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: First Italian series

Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats

Combat veterans, mental health issues, and the death penalty: addressing the impact of post-traumatic stress disorder and traumatic brain injury

Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor

RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent

The educational value of pediatric emergency transport: By design or by default?

Medical education and resident work hours

A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo

Cardiovascular Profile of RWJ 29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dogs

In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S 1 ‘ Subsite and Its Implications to Structure-Based Drug Design

Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents. 4-Ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties

Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist

Suchergebnisse filtern